Evidence-Based Treatment for Schizophrenia and Bipolar Disorder in State Medicaid Programs

Evidence-Based Treatment for Schizophrenia and Bipolar Disorder in State Medicaid Programs

ASPE Research Brief
Published: Feb 01, 2012
Publisher: Washington, DC: U.S. Department of Health and Human Services, Office of Disability, Aging, and Long-Term Care Policy, Office of the Assistant Secretary for Planning and Evaluation

Download

Authors

Allison Barrett

Emily Caffery

Henry Ireys

As the largest payer of mental health services in the United States, Medicaid programs have an opportunity to promote high-quality care for serious and persistent mental illnesses (SPMI) through the use of reimbursement strategies and policies that encourage the delivery of evidence-based practices (EBPs). These EBPs, which include pharmacologic, psychosocial, and physical health services, help beneficiaries with SPMI avoid costly institutional care, maintain employment, and engage in the community. However, few studies have examined the extent to which Medicaid beneficiaries with SPMI receive EPBs, and most of those studies have focused on Medicaid beneficiaries in a single state or smaller geographic area.

Efficiency Meets Impact.
That's Progress Together.

To solve their most pressing challenges, organizations turn to Mathematica for deeply integrated expertise. We bring together subject matter and policy experts, data scientists, methodologists, and technologists who work across topics and sectors to help our partners design, improve, and scale evidence-based solutions.

Work With Us